“Collaborative Innovation Center for Cancer Personalized Medicine” (Director: Hongbing Shen, Academician) is a high-level collaborative innovation center which is established based on Nanjing Medical University by the “college-led, government-supported, college-institution collaboration, and enterprise-joined” strategy. The center’s mission is to integrate basic research, medicine research, population prevention, and clinical diagnosis and treatment together and serve the “Healthy China” strategy. In 2014, the center was authorized as one of the province collaborative innovation centers in Jiangsu. In 2020, it was approved to jointly build by the Jiangsu province and the ministry of China. Meanwhile, the center won the A+ prize in the second phase evaluation, and it successfully entered the third construction period (2021-2024).
The center has gathered an excellent team of talents, including 3 academicians of the Chinese Academy of Engineering, 20 national leading talents (e.g., “National Science Fund for Distinguished Young Scholars” and “Chang-Jiang Scholar Professor”), and 16 young top talents (e.g., “National Science Fund for Excellent Young Scholars”). The center takes the key researcher (“Principal investigator”, PI) research group as the basic unit. There are four research directions in the center, each of which is led by one chief scientist and 10-14 PIs, including cancer personalized biological basis, personalized prevention, personalized diagnosis and personalized treatment of cancers. Taking cancer personalized medicine as a breakthrough point, the center intends to systematically analyze the biological mechanism underlying tumor heterogeneity, establish a new path of personalized prevention in the whole chain of “prediction-intervention-early warning-screening”, and develop intelligent solutions with independent intellectual property rights. The new system of cancer diagnosis and treatment and the multiple-full-accessible new products for personalized prevention, diagnosis and treatment of cancers will contribute to build a healthy China by providing our people with full life-cycle health services.
